No Data
No Data
No Data
No Data
No Data
Imagion Biosystems CEO Resigns
Imagion Biosystems (ASX:IBX) said Isaac Bright resigned as chief executive, effective Monday, to pursue other opportunities. Chair Bob Proulx will resume operating responsibilities as interim executiv
MT NewswiresJan 15 02:13 ET
Imagion Biosystems Validates Safety, Feasibility of Breast Cancer Imaging Agent in Phase One Trial; Shares Rise 7%
Imagion Biosystems (ASX:IBX) validated the safety and clinical feasibility of the MagSense HER2 imaging agent following results from a phase one clinical trial. The study met its safety and tolerabili
MT NewswiresDec 6, 2023 18:51 ET
Argenica Therapeutics Appoints Nonexecutive Chair
Argenica Therapeutics (ASX:AGN) appointed Dianne Angus as nonexecutive chair, effective Dec. 1, succeeding Geoff Pocock. Angus serves as director of Neuren Pharmaceuticals (ASX:NEU), Cyclopharm (ASX:C
MT NewswiresNov 29, 2023 22:06 ET
Imagion Biosystems Completes Phase 1 Imaging Agent Study
Imagion Biosystems (ASX:IBX) completed its imaging agent phase 1 study for MagSense to help detect human epidermal growth factor receptor 2-positive tumors, according to a Wednesday filing. The trial
MT NewswiresOct 18, 2023 05:49 ET
Imagion Biosystems Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2022
Imagion Biosystems (ASX:IBX) secured a AU$3.5 million rebate for the fiscal year ended June 30, 2022 from the Australian government's research and development tax incentive scheme. The refund is highe
MT NewswiresSep 19, 2023 01:56 ET
Stocks of the Hour: Sayona Mining, Tamboran Resources, Imagion Biosystems
Sayona Mining (ASX:SYA) announced that their preliminary technical study at their NAL lithium carbonate plant study produces an NPV of A$3.2bn. Sayona's Managing Director, Brett Lynch commented: "Sign
sharecafeJun 20, 2023 22:10 ET
No Data
No Data